{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:14:08Z","timestamp":1793315648411,"version":"4.5.0"},"reference-count":79,"publisher":"National Academy of Sciences","issue":"14","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R35CA210065"],"award-info":[{"award-number":["R35CA210065"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA013696"],"award-info":[{"award-number":["P30CA013696"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2025,4,8]]},"abstract":"<jats:p>\n                    Gamma Secretase Inhibitors (GSIs) effectively block oncogenic Notch homolog-1 (NOTCH1), a characteristic feature of T cell acute lymphoblastic leukemias (T-ALL). However, their clinical application has been stalled by the induction of severe gastrointestinal toxicity resulting from the inhibition of NOTCH signaling in the gut, which translates into increased goblet cell differentiation. Genome-wide CRISPR loss-of-function screen in the colon cancer cell line LS174T identified the neddylation pathway as a main regulator of goblet cell differentiation upon NOTCH1 inhibition. Consistently, pharmacologic inhibition of the neddylation pathway with the small molecule inhibitor MLN4924, rescued GSI-induced differentiation in LS174T cells. Mechanistically, neddylation inhibition by MLN4924 increases the protein stability of Hairy and enhancer of split-1, a direct NOTCH1 transcriptional target and key regulator of absorptive and secretory cell fate decisions. Combined treatment with GSI and MLN4924 in a murine\n                    <jats:italic>Notch1<\/jats:italic>\n                    -dependent model of T-ALL led to leukemia regression and improved overall survival in the absence of gut toxicity. Overall, these results support the combined targeting of the NOTCH1 and neddylation pathways for the treatment of NOTCH1-induced T-ALL.\n                  <\/jats:p>","DOI":"10.1073\/pnas.2426742122","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T15:01:18Z","timestamp":1743433278000},"update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":9,"title":["Therapeutic targeting of the NOTCH1 and neddylation pathways in T cell acute lymphoblastic leukemia"],"prefix":"10.1073","volume":"122","author":[{"given":"Kalay","family":"Bertulfo","sequence":"first","affiliation":[{"name":"Institute for Cancer Genetics, Columbia University","place":["New York"]},{"name":"Department of Biological Sciences, Columbia University","place":["New York"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0702-2712","authenticated-orcid":false,"given":"Pablo","family":"Perez-Duran","sequence":"additional","affiliation":[{"name":"Institute for Cancer Genetics, Columbia University","place":["New York"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1959-4104","authenticated-orcid":false,"given":"Hannah","family":"Miller","sequence":"additional","affiliation":[{"name":"Institute for Cancer Genetics, Columbia University","place":["New York"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Ma","sequence":"additional","affiliation":[{"name":"Institute for Cancer Genetics, Columbia University","place":["New York"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Ambesi-Impiombato","sequence":"additional","affiliation":[{"name":"Institute for Cancer Genetics, Columbia University","place":["New York"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Samon","sequence":"additional","affiliation":[{"name":"Institute for Cancer Genetics, Columbia University","place":["New York"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Mackey","sequence":"additional","affiliation":[{"name":"Institute for Cancer Genetics, Columbia University","place":["New York"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hsuan Wendy","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Medical Center","place":["New York"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo A.","family":"Ferrando","sequence":"additional","affiliation":[{"name":"Institute for Cancer Genetics, Columbia University","place":["New York"]},{"name":"Department of Pathology and Cell Biology, Columbia University Medical Center","place":["New York"]},{"name":"Department of Pediatrics, Columbia University Medical Center","place":["New York"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9851-3207","authenticated-orcid":false,"given":"Teresa","family":"Palomero","sequence":"additional","affiliation":[{"name":"Institute for Cancer Genetics, Columbia University","place":["New York"]},{"name":"Department of Pathology and Cell Biology, Columbia University Medical Center","place":["New York"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"e_1_3_4_1_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)62187-4"},{"key":"e_1_3_4_2_2","doi-asserted-by":"crossref","first-page":"(3)","DOI":"10.1101\/cshperspect.a035246","article-title":"The genetics and mechanisms of T-cell acute lymphoblastic leukemia","volume":"10","author":"Gianni F.","year":"2020","unstructured":"F. Gianni, L. Belver, A. Ferrando, The genetics and mechanisms of T-cell acute lymphoblastic leukemia. Cold Spring Harb. Perspect. Med. 10, (3) (2020).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27617"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13142"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1102160"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032712-100024"},{"key":"e_1_3_4_7_2","first-page":"163","article-title":"Recent advances on NOTCH signaling in T-ALL","volume":"360","author":"Tzoneva G.","year":"2012","unstructured":"G. Tzoneva, A. A. Ferrando, Recent advances on NOTCH signaling in T-ALL. Curr. Top Microbiol. Immunol. 360, 163\u2013182 (2012).","journal-title":"Curr. Top Microbiol. Immunol."},{"issue":"3","key":"e_1_3_4_8_2","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.3816\/CLM.2009.s.013","article-title":"Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia","volume":"9","author":"Palomero T.","year":"2009","unstructured":"T. Palomero, A. Ferrando, Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia. Clin. Lymphoma Myeloma 9 (suppl. 3), S205\u2013S210 (2009).","journal-title":"Clin. Lymphoma Myeloma"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-10-0034"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.80"},{"key":"e_1_3_4_11_2","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1182\/blood.V124.21.968.968","article-title":"The safety and activity of BMS-906024, a gamma secretase inhibitor (GSI) with anti-Notch activity, in patients with relapsed T-cell acute lymphoblastic leukemia (T-ALL): Initial results of a Phase 1 trial","volume":"124","author":"Zweidler-McKay P. A.","year":"2014","unstructured":"P. A. Zweidler-McKay , The safety and activity of BMS-906024, a gamma secretase inhibitor (GSI) with anti-Notch activity, in patients with relapsed T-cell acute lymphoblastic leukemia (T-ALL): Initial results of a Phase 1 trial. Blood 124, 968 (2014).","journal-title":"Blood"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M307757200"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfh254"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M311652200"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1242\/dev.01644"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature03659"},{"key":"e_1_3_4_17_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2165\/00126839-200607020-00003","article-title":"Gamma-secretase inhibitors for Alzheimer\u2019s disease: Balancing efficacy and toxicity","volume":"7","author":"Barten D. M.","year":"2006","unstructured":"D. M. Barten, J. E. Meredith Jr., R. Zaczek, J. G. Houston, C. F. Albright, Gamma-secretase inhibitors for Alzheimer\u2019s disease: Balancing efficacy and toxicity. Drugs R D 7, 87\u201397 (2006).","journal-title":"Drugs R D"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1001\/archneurol.2012.2194","article-title":"Safety and tolerability of the gamma-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease","volume":"69","author":"Coric V.","year":"2012","unstructured":"V. Coric , Safety and tolerability of the gamma-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease. Arch. Neurol. 69, 1430\u20131440 (2012).","journal-title":"Arch. Neurol."},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/onco.13627"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-030212-183741"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ydbio.2015.03.012"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1113\/JP271667"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.05.081"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ydbio.2010.07.026"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21611"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1242\/dev.069070"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.12.174"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau6246"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1922606117"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.75"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1611831114"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00702340"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2009.09.020"},{"key":"e_1_3_4_34_2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4149\/neo_2011_04_343","article-title":"Gamma-secretase inhibitor, a potential target therapy for MUC2-positive colorectal carcinoma","volume":"58","author":"Bu X.","year":"2011","unstructured":"X. Bu, N. Li, X. Tian, P. Huang, Gamma-secretase inhibitor, a potential target therapy for MUC2-positive colorectal carcinoma. Neoplasma 58, 343\u2013347 (2011).","journal-title":"Neoplasma"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1242\/dev.070763"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0813221106"},{"key":"e_1_3_4_37_2","unstructured":"K. Bertulfo P. Perez Duran Data from \u201cTherapeutic targeting of NOTCH1 and the neddylation pathway in T cell acute lymphoblastic leukemia. LS174T.\u201d Gene Expression Omnibus. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?&acc=GSE245371. Deposited 13 October 2023."},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01194-09"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.07.023"},{"key":"e_1_3_4_40_2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1083\/jcb.116.2.405","article-title":"A strategy for isolation of cDNAs encoding proteins affecting human intestinal epithelial cell growth and differentiation: Characterization of a novel gut-specific N-myristoylated annexin","volume":"116","author":"Wice B. M.","year":"1992","unstructured":"B. M. Wice, J. I. Gordon, A strategy for isolation of cDNAs encoding proteins affecting human intestinal epithelial cell growth and differentiation: Characterization of a novel gut-specific N-myristoylated annexin. J. Cell Biol. 116, 405\u2013422 (1992).","journal-title":"J. Cell Biol."},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00647"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/73.6.1131S"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00181.2017"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2015.140"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024484"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37301-3"},{"key":"e_1_3_4_47_2","doi-asserted-by":"crossref","unstructured":"K. Bertulfo P. Perez Duran Data from \u201cTherapeutic targeting of NOTCH1 and the neddylation pathway in T cell acute lymphoblastic leukemia. Mus musculus.\u201d Gene Expression Omnibus. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?&acc=GSE245370. Deposited 13 October 2023.","DOI":"10.1158\/1538-7445.AM2023-3928"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1100981108"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1353905"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ydbio.2010.06.021"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ydbio.2007.09.047"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.381806"},{"key":"e_1_3_4_53_2","doi-asserted-by":"crossref","first-page":"19489","DOI":"10.1038\/s41598-019-55292-7","article-title":"Intestinal Neurod1 expression impairs paneth cell differentiation and promotes enteroendocrine lineage specification","volume":"9","author":"Li H. J.","year":"2019","unstructured":"H. J. Li , Intestinal Neurod1 expression impairs paneth cell differentiation and promotes enteroendocrine lineage specification. Sci. Rep. 9, 19489 (2019).","journal-title":"Sci. Rep."},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.06.044"},{"key":"e_1_3_4_55_2","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.153045","article-title":"MTG16 regulates colonic epithelial differentiation, colitis, and tumorigenesis by repressing E protein transcription factors","volume":"7","author":"Brown R. E.","year":"2022","unstructured":"R. E. Brown , MTG16 regulates colonic epithelial differentiation, colitis, and tumorigenesis by repressing E protein transcription factors. JCI Insight 7, e153045 (2022).","journal-title":"JCI Insight"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201306-1181OC"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI79422"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1113\/JP271754"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0256774"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.15-278606"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2016.59"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-018-0113-7"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2014.12.006"},{"key":"e_1_3_4_64_2","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1242\/dev.106989","article-title":"Tcf3 expression marks both stem and progenitor cells in multiple epithelia","volume":"141","author":"Howard J. M.","year":"2014","unstructured":"J. M. Howard, J. M. Nuguid, D. Ngole, H. Nguyen, Tcf3 expression marks both stem and progenitor cells in multiple epithelia. Development 141, 3143\u20133152 (2014).","journal-title":"Development"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(03)00468-6"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3919"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1177\/1947601910382898"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2012.707192"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1900"},{"key":"e_1_3_4_70_2","doi-asserted-by":"crossref","first-page":"23812","DOI":"10.18632\/oncotarget.8068","article-title":"The NEDD8-activating enzyme inhibitor MLN4924 induces G2 arrest and apoptosis in T-cell acute lymphoblastic leukemia","volume":"7","author":"Han K.","year":"2016","unstructured":"K. Han , The NEDD8-activating enzyme inhibitor MLN4924 induces G2 arrest and apoptosis in T-cell acute lymphoblastic leukemia. Oncotarget 7, 23812\u201323824 (2016).","journal-title":"Oncotarget"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1636"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3665"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.1"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.815001"},{"key":"e_1_3_4_75_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13045-023-01485-7","article-title":"Targeting NEDD8-activating enzyme for cancer therapy: Developments, clinical trials, challenges and future research directions","volume":"16","author":"Fu D. J.","year":"2023","unstructured":"D. J. Fu, T. Wang, Targeting NEDD8-activating enzyme for cancer therapy: Developments, clinical trials, challenges and future research directions. J. Hematol. Oncol. 16, 87 (2023).","journal-title":"J. Hematol. Oncol."},{"key":"e_1_3_4_76_2","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1038\/s41375-021-01125-4","article-title":"Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS\/CMML or low-blast AML","volume":"35","author":"Sekeres M. A.","year":"2021","unstructured":"M. A. Sekeres , Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS\/CMML or low-blast AML. Leukemia 35, 2119\u20132124 (2021).","journal-title":"Leukemia"},{"key":"e_1_3_4_77_2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S1470-2045(23)00246-2","article-title":"Gamma-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: A phase 1, first-inhuman trial","volume":"24","author":"Cowan A. J.","year":"2023","unstructured":"A. J. Cowan , Gamma-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: A phase 1, first-inhuman trial. Lancet Oncol. 24, 811\u2013822 (2023).","journal-title":"Lancet Oncol."},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404258"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2017.016"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.2426742122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T15:05:15Z","timestamp":1743433515000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/10.1073\/pnas.2426742122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":79,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025,4,8]]}},"alternative-id":["10.1073\/pnas.2426742122"],"URL":"https:\/\/doi.org\/10.1073\/pnas.2426742122","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"assertion":[{"value":"2024-12-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2426742122"}}